Answers are grounded in this paper and cite their sources.
The tuberculosis drug bedaquiline inhibits mycobacterial F-ATP synthase by binding to its c subunit. Using the purified ε subunit of the synthase and spectroscopy, we previously demonstrated that the drug interacts with this protein near its unique tryptophan residue. Here, we show that replacement of ε's tryptophan with alanine resulted in bedaquiline hypersusceptibility of the bacteria. Overexpression of the wild-type ε subunit caused resistance. These results suggest that the drug also targets the ε subunit.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: